2022

  1. Mirikizumab phase 2 in CD

  2. Steroid exposure and perinatal outcomes

  3. AntiTNF and surgery in perianal CD

  4. Self-expandable metal stents vs endoscopic balloon dilation for the treatment of strictures in Crohn’s disease

  5. AntiTNF impact on IBD surgery

  6. Infliximab IV to SC in IBD

  7. Adalimumab eow vs ew in CD

  8. Adalimumab eow vs ew in UC

  9. Ustekinumab in CD. Treat to target or standard of care